Arun Bhardwaj
Overview
Explore the profile of Arun Bhardwaj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galhotra A, Veetil D, Wadhawan R, Bhardwaj A, Verma N
J Minim Access Surg
. 2024 Nov;
21(1):86-88.
PMID: 39495723
Foreign body (FB) ingestion results in perforation in 1% of cases and is associated with significant morbidity and rarely mortality. This case reports the delayed presentation of distal ileal perforation...
2.
Patt D, Patel A, Bhardwaj A, Hudson K, Christman A, Amondikar N, et al.
JCO Clin Cancer Inform
. 2023 Oct;
7:e2300182.
PMID: 37897263
Purpose: There is raising interest to implement electronic patient-reported outcomes (ePROs) for symptom monitoring to enhance the quality of cancer care. Step 1 of the Texas Two-Step Study demonstrated successful...
3.
Ramkumar S, Bhardwaj A, Patel A, Seetharaman K, Christman A, Amondikar N, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Aug;
149(10):912-918.
PMID: 37651149
Importance: The US Food and Drug Administration approved immune checkpoint inhibitors (immunotherapy) for select cases of head and neck squamous cell carcinoma (HNSCC) in 2016. However, it is unclear whether...
4.
Canick J, Bhardwaj A, Patel A, Kuziez D, Larsen R, Misra S, et al.
JCO Oncol Pract
. 2022 Dec;
19(3):e397-e406.
PMID: 36480772
Purpose: While pain is prevalent among survivors of head and neck cancer (HNC), there is a lack of data on pain management in the community oncology setting. We described sociodemographic...
5.
Khushman M, Patel G, Laurini J, Bhardwaj A, Roveda K, Donnell R, et al.
J Gastrointest Oncol
. 2019 Aug;
10(4):695-702.
PMID: 31392050
Background: Exosomes are important mediators of intercellular communications and play pivotal roles in cancer progression, metastasis and chemoresistance. CD63 and CD9 are widely accepted exosomal markers. In patients with pancreatic...
6.
Zubair H, Bhardwaj A, Ahmad A, Srivastava S, Khan M, Patel G, et al.
Nutr Cancer
. 2017 Jul;
69(6):932-942.
PMID: 28718667
Scope: Hydroxytyrosol (HT), a polyphenol from olives, is a potential anticancer agent. This study was designed to evaluate the anticancer activity of HT against prostate cancer cells, and the mechanism...
7.
Khushman M, Bhardwaj A, Patel G, Laurini J, Roveda K, Tan M, et al.
Pancreas
. 2017 Jun;
46(6):782-788.
PMID: 28609367
Objectives: Exosomes are important mediators in intercellular communications and play a role in cancer progression and metastasis. Exosomal membranes are enriched in endosome-specific tetraspanins (CD9 and CD63). Here, we explored...
8.
Khan M, Azim S, Zubair H, Bhardwaj A, Patel G, Khushman M, et al.
Int J Mol Sci
. 2017 Apr;
18(4).
PMID: 28383487
Pancreatic cancer (PC) continues to rank among the most lethal cancers. The consistent increase in incidence and mortality has made it the seventh leading cause of cancer-associated deaths globally and...
9.
Deshmukh S, Srivastava S, Zubair H, Bhardwaj A, Tyagi N, Al-Ghadhban A, et al.
Cancer Lett
. 2017 Mar;
396:21-29.
PMID: 28302531
Breast cancer (BC) continues to be the most frequently diagnosed cancer in American women, which disproportionately affects women of African-American (AA) descent. Previously, we reported greater serum levels of resistin...
10.
Patel G, Khan M, Bhardwaj A, Srivastava S, Zubair H, Patton M, et al.
Br J Cancer
. 2017 Feb;
116(5):609-619.
PMID: 28152544
Background: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced...